PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Starting soon · Phase 4

Conditions studied: Type 2 Diabetes, Type 2 Diabetes (T2DM)

In brief

The purpose of this research study is to look at whether Eroxon® gel when used together with tadalafil, may help improve erectile function in men ages 18 to 40 who have type 2 diabetes.

Key facts

Study ID

NCT07636161

Run by

University of Miami

People needed

30

Starts

2026-09-01

Expected to finish

2027-09-01

Last updated by the study team

2026-06-09

Who can join

Age: 18 and older, up to 40. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male sex at birth
• Age 18-40 years
• Diagnosis of type 2 diabetes mellitus
• Diagnosis of erectile dysfunction
• Currently prescribed tadalafil
• Have a sexual partner willing to complete a survey
• Ability to provide informed consent

You may not qualify if…

• Type 1 diabetes mellitus
• Severe psychiatric illness that would impair participation
• Use of nitrates or contraindications to sexual activity
• Known allergy to Eroxon® gel components
• Participation in another interventional sexual health study

Where it is running

• Don Soffer Clinical Research Building — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.